Clinical Trial Information

The following is a list of all current Geron-sponsored clinical trials. Click on the links below for more information about a specific product or trial.

Oncology

Telomerase Inhibitor - Imetelstat (GRN163L)

Disease Indication		Single or Combination Therapy		Patient Enrollment Status		More Information
Chronic Lymphoproliferative Disease		Single Agent		Completed		Phase I Trial
Solid Tumors		Single Agent		Open		Phase I Trial
Non-Small Cell Lung Cancer		Combination with paclitaxel and carboplatin		Completed		Phase I Trial
Multiple Myeloma		Single Agent		Completed		Phase I Trial
Multiple Myeloma		Combination with bortezomib with or without dexamethasone		Completed		Phase I Trial
Breast Cancer		Combination with paclitaxel and bevacizumab		Open		Phase I/II Trial

The following Phase II clinical trials of imetelstat are open for enrollment:

Disease Indication		Single or Combination Therapy		Patient Enrollment Status		More Information
Non-Small Cell Lung Cancer		Single agent maintenance therapy		Open		Phase II Trial

Telomerase Cancer Vaccine - GRNVAC1

Disease Indication		Patient Enrollment Status		More Information
Acute Myelogenous Leukemia (AML)		Completed		Phase II Trial

Regenerative Medicine

There are currently no clinical trials of our products derived from human embryonic stem cells (hESCs). For more information click here.